Skip to main content
. 2021 May 11;11(5):e045074. doi: 10.1136/bmjopen-2020-045074

Table 2.

Sleep disturbances at baseline among women in SWAN included in the primary cohort

No sleep medication
n=447
Sleep medication user
n=238
SMD
Trouble initiating sleep, mean (95% CI)* 2.6 (2.5 to 2.7) 2.7 (2.5 to 2.9) 0.08
Waking frequently, mean (95% CI)* 3.7 (3.6 to 3.9) 3.8 (3.6 to 3.9) 0.03
Early morning awakening, mean (95% CI)* 2.7 (2.6 to 2.8) 2.8 (2.6 to 3.0) 0.07
Trouble initiating sleep, at least three nights per week, n (%) 137 (30.7) 82 (34.5) 0.07
Waking frequently, at least three nights per week, n (%) 291 (65.1) 158 (66.4) 0.008
Early morning awakening, at least three nights per week, n (%) 135 (30.2) 81 (34.0) 0.07
Any disturbance, at least three nights per week, n (%) 322 (72.0) 183 (76.9) 0.08

*Mean calculated based on 5-point Likert scale, where 1=no difficulties on any nights, 2=difficulties on less than one night per week, 3=one to two nights per week, 4=three to four nights per week and 5=five to seven nights per week.

SMD, standardised mean difference; SWAN, Study of Women’s Health Across the Nation.